AdaptHealth Stock Price, News & Analysis (NASDAQ:AHCO)

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares.
View AHCO analyst ratings or view top-rated stocks.

6 brokers have issued 12 month price targets for AdaptHealth's stock. Their AHCO share price targets range from $6.50 to $23.00. On average, they predict the company's stock price to reach $13.83 in the next year. This suggests a possible upside of 64.6% from the stock's current price.
View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts.

AdaptHealth's stock was trading at $19.22 at the beginning of the year. Since then, AHCO shares have decreased by 56.3% and is now trading at $8.40.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our AHCO earnings forecast.

AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.19 EPS for the quarter, meeting analysts' consensus estimates of $0.19. The business earned $804.03 million during the quarter, compared to analysts' expectations of $796.60 million. AdaptHealth had a positive trailing twelve-month return on equity of 4.09% and a negative net margin of 13.68%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.11 earnings per share.

ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap Value with Momentum ETF (XSVM), Invesco S&P SmallCap Health Care ETF (PSCH), Harbor Small Cap Explorer ETF (QWST), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and EA Bridgeway Omni Small-Cap Value ETF (BSVO).Syntax Stratified SmallCap ETF (SSLY).

Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS).

AdaptHealth's stock is owned by a number of institutional and retail investors. Top institutional investors include Deerfield Management Company L.P. Series C (10.00%), FMR LLC (6.49%), SkyKnight Capital L.P. (6.30%), Reinhart Partners LLC. (2.66%), Rubric Capital Management LP (1.44%) and Rubric Capital Management LP (1.44%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.